Serina Therapeutics director Simon Farrell files initial beneficial ownership statement
SERA•Form 3 filing by director
- Serina Therapeutics director Simon Farrell filed an initial Form 3 on July 23, 2026.
Related News
Thrivent Financial for Lutherans sells USD 28,282 of Gloo Holdings common shares
GLOO•
Oklo Receives DOE Startup Authorization for Groves Isotope Test Reactor
OKLO•
Jefferies LLC, Jefferies Financial subsidiary, posts USD 38.77 billion total assets as of May 31, 2026
JEF•
Intel CEO - Factories Exceeded Volume Targets During Q2 - Conf Call
INTC•
Provident Financial declares quarterly cash dividend of $0.14 a share
PROV•